Headlines Specialties Covid-19 Trending Feeds ASCO20 Videos

Is It Time to Add Checkpoint Inhibitors to the Treatment of Locally Advanced Lung Cancer – The ASCO Post

ascopost.com - After more than 20 years of failed strategies to improve survival rates for locally advanced lung cancers, checkpoint inhibitors have revolutionized therapy, but prognoses still lag behind other tumor types. During the ASCO20 Virtual Education Program, Mark G. Kris, MD, FASCO, a thoracic medical oncologist at Memorial...

Read the full article here

Related Content